Michael Halstead Net Worth & Insider Trades
Michael Halstead - EVP and General Counsel, Intra-Cellular Therapies, Inc
What is Michael Halstead's Net Worth?
The current estimated net worth of Intra-Cellular Therapies, Inc's EVP and General Counsel, Michael Halstead, is estimated to be about $24.83M . Michael Halstead owns about 0 unit of Intra-Cellular Therapies, Inc common stock. In the last 9 years at Intra-Cellular Therapies, Inc, Michael Halstead has sold an estimated value of $23.77M worth.
What is Michael Halstead's Past Insider Trading?
Michael Halstead's largest purchase order was 176,863 units , worth over $2.9M on December 23, 2021. Michael Halstead's largest sale order was 176,863 units , worth over $8.41M on December 23, 2021. In total, Michael Halstead has made about 31 transactions over 9 years of their time at Intra-Cellular Therapies, Inc. Michael Halstead usually trades in January, with the busiest year in 2020. The most recent transaction was a sale order of 50,000 units , worth over $2.69M on November 14, 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Michael Halstead
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Michael Halstead's Salary in 2020?
As EVP and General Counsel of Intra-Cellular Therapies, Inc, Michael Halstead has a total base salary of $512,000 . Michael Halstead received compensation valued at about $2,449,906 in 2020 after becoming EVP and General Counsel. The vast majority of their compensation came in the form of a bonus of $320,000 , stock awards of $1,119,985 , option awards of $479,990 , and other compensation of $17,931 .
What is Michael Halstead's' Mailing Address?
- Mailing address is C/o Warner Chilcott Corporation 100 Enterprise Drive Rockaway NJ 07866 NJ
Intra-Cellular Therapies, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Sharon Mates, Ph.D. | 2020 | $766,800 | $690,120 | $2,799,998 | $1,199,994 | $18,767 | $5,475,679 |
| Sharon Mates, Ph.D. | 2019 | $744,500 | $759,400 | $1,599,996 | $1,600,003 | $20,661 | $4,724,560 |
| Sharon Mates, Ph.D. | 2018 | $722,800 | $585,500 | $1,593,735 | $1,556,410 | $18,024 | $4,476,469 |
| Lawrence J. Hineline | 2020 | $463,400 | $222,432 | $1,049,984 | $449,993 | $20,374 | $2,206,183 |
| Lawrence J. Hineline | 2019 | $449,900 | $225,000 | $749,988 | $749,995 | $18,648 | $2,193,531 |
| Lawrence J. Hineline | 2018 | $424,400 | $203,700 | $749,986 | $732,430 | $17,292 | $2,127,808 |
| Suresh Durgam, M.D. | 2020 | $448,575 | $274,400 | $599,984 | $599,997 | $7,385 | $1,930,341 |
| Michael I. Halstead | 2020 | $512,000 | $320,000 | $1,119,985 | $479,990 | $17,931 | $2,449,906 |
| Michael I. Halstead | 2019 | $497,100 | $323,100 | $749,988 | $749,995 | $17,270 | $2,337,453 |
| Michael I. Halstead | 2018 | $469,000 | $225,100 | $749,986 | $732,430 | $16,680 | $2,193,196 |
| Mark Neumann | 2020 | $518,900 | $324,312 | $1,119,985 | $479,990 | $130,085 | $2,573,272 |
| Mark Neumann | 2019 | $503,800 | $277,100 | $799,991 | $799,997 | $133,449 | $2,514,337 |
| Mark Neumann | 2018 | $106,090 | $245,500 | $749,995 | $749,990 | $25,124 | $1,876,699 |
| Andrew Satlin, M.D. | 2020 | $480,634 | $0 | $1,119,985 | $479,990 | $20,585 | $2,101,194 |
| Andrew Satlin, M.D. | 2019 | $515,000 | $360,500 | $874,997 | $874,996 | $19,332 | $2,644,825 |
| Andrew Satlin, M.D. | 2018 | $500,000 | $300,000 | $0 | $0 | $11,792 | $811,792 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1567514/000119312521140765/d80913ddef14a.htm
What are Intra-Cellular Therapies, Inc's Past Insider Trades?
Intra-Cellular Therapies, Inc's most recent insider trade came on November 14, 2023 by Michael Halstead who sold 50,000 units worth $2.69M . In the last 9 years, insiders at Intra-Cellular Therapies, Inc have sold an estimated value of $142.39M and bought an estimated value of $70.48M worth of shares. Insider trading is most common in January, with the busiest year in 2020. The most active traders at the company are Christopher Alafi, Director, Rory Riggs, Director, and Robert Nostrand Van, Director .
Intra-Cellular Therapies, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||